The basal plasma glucose: a simple relevant index of maturity-onset diabetes.

The basal plasma glucose: a simple relevant index of maturity-onset diabetes.

The 'basal' plasma glucose, defined as the stable overnight concentration, has been assessed as an index of diabetes control by comparison with plasma glucose measurements during 24-h profiles in diet-treated maturity-onset diabetic patients and normal subjects. The basal plasma glucose co...

Bibliográfalaš dieđut
Váldodahkkit:	Holman, R, Turner, R
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	1981

Geahča maid

Maintenance of basal plasma glucose and insulin concentrations in maturity-onset diabetes.
Dahkki: Holman, R, et al.
Almmustuhtton: (1979)

CONTROL OF MATURITY-ONSET DIABETES BY HOME OR CLINIC MONITORING OF FASTING PLASMA GLUCOSE
Dahkki: Howedavies, S, et al.
Almmustuhtton: (1978)

CLINICAL VALUE OF BASAL PLASMA GLUCOSE
Dahkki: Holman, R, et al.
Almmustuhtton: (1977)

CLINICAL VALUE OF BASAL PLASMA GLUCOSE
Dahkki: Holman, R, et al.
Almmustuhtton: (1977)

FASTING BLOOD-GLUCOSE CONCENTRATIONS AND TREATMENT OF MATURITY-ONSET DIABETES
Dahkki: Howedavies, S, et al.
Almmustuhtton: (1980)

BETA CELL DEFICIENCY IN MATURITY ONSET DIABETES
Dahkki: Turner, R, et al.
Almmustuhtton: (1976)

MATURITY-ONSET DIABETES IN YOUNG BLACK-AMERICANS
Dahkki: Orahilly, S, et al.
Almmustuhtton: (1987)

betacell function during insulin or chlorpropamide treatment of maturity-onset diabetes mellitus.
Dahkki: Turner, R, et al.
Almmustuhtton: (1978)

Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations.
Dahkki: Turner, R, et al.
Almmustuhtton: (1979)

Relative contributions of insulin deficiency and insulin resistance in maturity-onset diabetes.
Dahkki: Turner, R, et al.
Almmustuhtton: (1982)

Diabetes: The quest for basal normoglycaemia.
Dahkki: Holman, R, et al.
Almmustuhtton: (1977)

Brief, irregular oscillations of basal plasma insulin and glucose concentrations in diabetic man.
Dahkki: Lang, D, et al.
Almmustuhtton: (1981)

Non-uniform distribution of islet amyloid in the pancreas of 'maturity-onset' diabetic patients.
Dahkki: Clark, A, et al.
Almmustuhtton: (1984)

CYCLICAL VARIATION (HUNTING) OF BASAL PLASMA GLUCOSE AND INSULIN CONCENTRATIONS IN NORMAL AND DIABETIC MAN
Dahkki: Matthews, D, et al.
Almmustuhtton: (1978)

Basal normoglycemia attained with chlorpropamide in mild diabetes.
Dahkki: Holman, R, et al.
Almmustuhtton: (1978)

Home blood sampling for plasma glucose assay in control of diabetes.
Dahkki: Howe-Davies, S, et al.
Almmustuhtton: (1978)

Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings.
Dahkki: Lang, D, et al.
Almmustuhtton: (1979)

UK prospective study of therapies of maturity-onset diabetes.
Dahkki: Turner, R, et al.
Almmustuhtton: (1984)

CORRELATES OF DETERIORATING VIBRATION SENSITIVITY 3 YEARS FROM DIAGNOSIS OF MATURITY-ONSET DIABETES
Dahkki: Holman, R, et al.
Almmustuhtton: (1981)

A simple and rational twice daily insulin regime. Distinction between basal and meal insulin requirements.
Dahkki: Phillips, M, et al.
Almmustuhtton: (1979)

Sulphonylurea failure in type 2 diabetes: treatment with a basal insulin supplement.
Dahkki: Holman, R, et al.
Almmustuhtton: (1987)

COMPARISON OF TREATMENT OF MILD DIABETES WITH A BASAL INSULIN SUPPLEMENT OR SULFONYLUREA
Dahkki: Holman, R, et al.
Almmustuhtton: (1977)

Insulin rather than glucose homoeostasis in the pathophysiology of diabetes.
Dahkki: Turner, R, et al.
Almmustuhtton: (1976)

Optimizing blood glucose control in type 2 diabetes: an approach based on fasting blood glucose measurements.
Dahkki: Holman, R, et al.
Almmustuhtton: (1988)

From glucose sensing to exocytosis: takes from maturity onset diabetes of the young
Dahkki: Sama Samadli, et al.
Almmustuhtton: (2023-05-01)

Induced basal normoglycemia and altered platelet aggregation in non-insulin-dependent diabetes.
Dahkki: Evans, R, et al.
Almmustuhtton: (1982)

Beta-cell function improved by supplementing basal insulin secretion in mild diabetes.
Dahkki: Turner, R, et al.
Almmustuhtton: (1976)

A practical guide to basal and prandial insulin therapy.
Dahkki: Holman, R, et al.
Almmustuhtton: (1985)

The Fasting Hyperglycaemia Study: III. Randomized controlled trial of sulfonylurea therapy in subjects with increased but not diabetic fasting plasma glucose.
Dahkki: Karunakaran, S, et al.
Almmustuhtton: (1997)

The haemoglobin glycation index is reproducible in dysglycaemic individual but is not explained by post-challenge plasma glucose levels
Dahkki: Kim, J, et al.
Almmustuhtton: (2004)

Post-prandial glycaemic reduction by an alpha-glucosidase inhibitor in type 2 diabetic patients with therapeutically attained basal normoglycaemia.
Dahkki: Holman, R, et al.
Almmustuhtton: (1991)

The Fasting Hyperglycaemia Study: II. Randomized controlled trial of reinforced healthy-living advice in subjects with increased but not diabetic fasting plasma glucose.
Dahkki: Dyson, P, et al.
Almmustuhtton: (1997)

Microvascular and macrovascular disease in subjects with increased but not diabetic fasting glucose levels
Dahkki: Karunakaran, S, et al.
Almmustuhtton: (1996)

Associations of the triglyceride-glucose index and atherogenic index of plasma with the severity of new-onset coronary artery disease in different glucose metabolic states
Dahkki: Xiaosheng Wu, et al.
Almmustuhtton: (2024-02-01)

TWICE-DAILY SUBCUTANEOUS HUMAN PROINSULIN PROVIDES A SATISFACTORY BASAL INSULIN SUPPLEMENT IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS
Dahkki: Holman, R, et al.
Almmustuhtton: (1987)

Pancreatic islet amyloid and elevated proinsulin secretion in familial maturity-onset diabetes.
Dahkki: Clark, A, et al.
Almmustuhtton: (1987)

Mature onset diabetes of the young (MODY).
Dahkki: E Lacerda Nobre, et al.
Almmustuhtton: (2002-12-01)

Maturity-Onset Diabetes of the Young Identified Among Algerian Probands with Early-Onset Diabetes
Dahkki: Bouldjennet F, et al.
Almmustuhtton: (2020-12-01)

MATURITY-ONSET DIABETES OF THE YOUNG IS A BETA-CELL DISORDER WITH NORMAL PROINSULIN LEVELS
Dahkki: Hattersley, A, et al.
Almmustuhtton: (1993)

Predicting post one-year durability of glucose-lowering monotherapies in patients with new-onset type 2 diabetes
Dahkki: Agbaje, O, et al.
Almmustuhtton: (2017)